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Contraception of Wild and Feral Equids 
Jay F. Kirkpatrick, J. W.Turner, Jr., and I.K.M. L iu 
Abstract: Fertility control in wild horses has been contraceptive effects for a second year, and the vaccine's 
attempted with both stallions and mares. Nonreversible effects are reversible after short-term use. 
surgical sterilization by means of vasectomy has been After 6 years of treating 52 different mares with 
successful in inhibiting reproduction in wild horses in porcine zonae pellucidae, contraceptive efficacy exceeded 
Montana and Nevada. Administration of a microencapsulated 95 percent. In more recent studies, investigators are studying 
form of testosterone to wild stallions reduced sperm counts the effects of long-term treatment (4 to 7 consecutive years) 
and motilitv and foal counts. In a third ap~roach. lntra~eri- upon ovarian function. The  orc cine zona Dellucida 1PZPI 
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years 
The first immunological fertility control of free-ranging 
wildlife was accomplished with wild horses, Initial experi- 
ments demonstrated that immunization with porcine zonae 
pellucidae was capable of causing contraception in 
domestic mares. Later, contraception was achieved with 
the vaccine in free-ranging horses. That study demon- 
strated that the vaccine (1) could be delivered remotely via 
darts, (2) was safe to administer to pregnant animals, and 
(3) did not alter social behavior. A followup study revealed 
that a single annual booster inoculation would extend the 
Introduction 
Over the past 20 years, advances in wildlife contra- 
ception have been driven largely by concern over 
increases in wild horse (Equus caballus) populations. 
Prior to 1971 in North America, wild horse populations 
were controlled by the removal of horses from range- 
land and their sale for various commercial purposes. 
The passage of the Wild Horse and Burro Act (P.L. 
92-195) in 1971 by the U.S. Congress provided 
almost complete protection to wild and feral equids on 
public lands. At the time of the passage of this law, 
there were an estimated 17,000 wild horses on U.S. 
public lands. In an attempt to provide some form of 
population control, the U.S. Department of the 
. . 
Interior's Bureau of Land Management, the agency 
responsible for management of wild horses in the 
United States, initiated the Adopt-a-Horse program. 
Horses were gathered and adopted by people inter- 
ested in acquiring a wild horse. However, the high 
cost of this program, its inability to remove sufficiently 
large numbers of horses, and increased reproductive 
success by the horses remaining on rangelands led to 
steady population increases between 1970 and 1980. 
By 1980, the estimated number of wild horses on 
poublic lands had increased to somewhere between 
captive ~rzewalski's horses, andbnagers. Tests are 
currently under way on 150 feral horses in Nevada for the 
purpose of developing a one-inoculation form of the PZP 
vaccine that will deliver from 1 to 3 years of contraceDtive 
prorecl on An n t al f,e o rest of in s vacclne no cat& a 
n qn oeqree of sbccess LN in a s na e mot- a1 on o/er a 
s ng e Gar and a I e a test of a second-general on of 
m croca~s~les a so ino caleo a ntan oearee of conlraceD1,ve 
efficacyover a single year. 
- 
Keywords: equids, immunocontraception, porcine zonae 
pellucida, wildlife contraception 
60,000 and 80,000. Clearly, alternative control 
methods were necessary. 
Chemically or immunologically induced inhibition 
of fertility in equids has been little studied. Historically, 
equine fertility control has focused on castration of the 
domestic stallion. Most often, this common procedure 
is carried out not only to prevent reproduction but also 
to reduce testicular androgen production and accom- 
panying aggressive behavior. Recently, interest in 
contraception of the equids has increased, largely 
because of uncontrolled populations of free-roaming 
wild horses and feral burros (E. asinus). 
Contraception of the Stallion 
Initial attempts at chemical contraception of wild 
horses focused on the stallion and attempted to exploit 
the haremlike social structure common to the majority 
of wild equids. To test the concept, two adult wild 
stallions inhabiting the Pryor Mountain Wild Horse 
Refuge in Montana were vasectomized and permitted 
to return to their bands. After 2 years, no foals appeared 
among the mares accompanying the vasectomized 
Contraception in Wildlife Management 
stallions (Kirkpatrick 1982). When this experiment 
was later repeated with larger numbers of wild stallions 
in Nevada, the results indicated that dominant stallions 
were responsible for the vast majority of successful 
breedings (Eagle et al. 1993). 
Several potential contraceptive compounds, 
including testosterone cypionate, testosterone propi- 
onate, quinestrol (17~-ethinylestradiol 3-cyclopentyl 
ether), 17P estradiol, and a-chlorohydrin (3-chloro- 
1,2-propanediol) were tested in domestic pony 
stallions. The a-chlorohydrin led to neurological 
disorders, so tests were discontinued. Repeated 
intramuscular injections of the two androgens and 
quinestrol (1.7 g per 100 kg of body weight, monthly 
x 6 months) resulted in significant oligospermia and a 
significant reduction in sperm motility, but Silastic 
implants contraining estradiol failed to achieve signifi- 
cant reductions in sperm counts, probably because of 
poor release rates (Kirkpatrick 1982, Turner and 
Kirkpatrick 1982). 
A microencapsulated form of testosterone 
propionate (mTP) was selected for field tests of 
contraceptive efficacy in wild horses in Challis, ID. 
The microencapsulation polymer (D,L-lactide) coating 
(Southern Research Institute, Birmingham, AL) 
permitted a sustained release for up to 6 months after 
intramuscular (i.m.) injection. On contact with intercel- 
lular water, the lactide coating erodes and releases 
the active steroid. The coating is converted to carbon 
dioxide and lactic acid. 
Fifteen wild stallions-seven experimental 
subjects and eight controls-were located by helicop- 
ter and darted with approximately 300 mg succinylcho- 
line. After immobilization, stallions received i.m. 
injections of 5, 7.5, or 10 g mTP in the hip. Stallion 
libido and quantitative aspects of sexual behavior, 
based on elimination marking behavior (Turner et al. 
1981), were unaffected, and breeding took place. 
There was an 83-percent reduction in foal production 
compared with mares bred by control stallions (2 v. 13 
foals, respectively), with no differences between 
fertility and the doses of mTP administered 
(Kirkpatrick et al. 1982, Turner and Kirkpatrick 1982). 
Concerns for the safety of the stallions, dangers 
of immobilization, and high cost of opioid immobilizing 
drugs (approximately $50/dose of etorphine and 
reversal agent) led to an attempt to deliver 3 g mTP 
remotely to wild harem stallions on Assateague Island 
National Seashore, by means of barbless darts. In 
this study, the stallions were located and darted from 
the ground without capture or immobilization. The 
pharmacologic success of mTP contraception was 
evident; there was a 28.9-percent fertility rate for the 
mares accompanying treated stallions and an approxi- 
mate 45-percent fertility rate among control mares. 
However, the difficulties of delivering 3 g mTP in four 
separate doses to each stallion were discouraging 
(Kirkpatrick and Turner 1987, Turner and Kirkpatrick 
1991). 
Contraception in the Mare 
Steroids 
The difficulty of darting a stallion up to four times plus 
concerns over band infidelity by mares turned the 
focus of wild horse contraception to the mare. Attempts 
were made to administer contraceptive doses of 
progestins to wild mares. Based on experience with 
persistent corpora lutea (Stabenfeldt et al. 1974) and 
data which indicated that plasma progesterone 
concentrations in excess of 0.5 to 1 ngImL inhibited 
ovulation in the mare (Squires et al. 1974, Noden et 
al. 1978, Palmer and Jousset 1975), microencapsu- 
lated northisterone (norethindrone, mNET) was 
administered remotely, with barbless darts, to six wild 
mares on Assateague Island (Kirkpatrick and Turner 
1987, Turner and Kirkpatrick 1991). This particular 
progestin, which had been used successfully to inhibit 
fertility in women, was given at a dose of approxi- 
mately 2 g, in microcapsules similar to those used in 
previous studies with testosterone propionate. All six 
mares receiving the mNET produced a foal a year 
later-a highly improbable event among Assateague 
mares, where annual foaling rates seldom exceed 55 
percent (Keiper and Houpt 1984). 
In another experiment, groups of 30 captive wild 
mares in Nevada were each implanted with Silastic 
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rods containing 8 g estradiol (E), 24 g progesterone 
(P), 8 g E plus 8 g P, 4 g E plus 12 g P, 12 g E plus 
12 g P, or no hormone (Vevea et al. 1987, Plotka et al. 
1988). Fewer mares receiving 8 g E, 4 g E plus 12 g P, 
or 8 g E plus 8 g P displayed estrus, but all animals 
displaying estrus-treated or control-ovulated. 
These data indicated a rapid decline in plasma steroid 
concentrations within 5 weeks of receiving steroid 
implants and suggested increased metabolic clear- 
ance of the steroid, an event that would also explain 
the failure of the mNET treatments described above. 
Because of the rapid decline in E and P concentra- 
tions, Silastic implants containing the synthetic estro- 
gen ethinylestradiol (EE2) or EE2 plus P were placed 
in captive wild mares (Plotka et al. 1989). Animals 
pregnant at the time of implantation delivered healthy 
foals. Contraceptive efficacy ranged from 88 percent 
to 100 percent through two breeding seasons and was 
approximately 75 percent for three seasons. Endo- 
crine studies of these mares suggested that contra- 
ception occurred by blocking ovulation andlor 
implantation. 
In a similar study, intraperitoneal implants of 1.5, 
3, or 8 g EE2 alone also resulted in contraceptive 
efficacy of 75 percent to I 0 0  percent through two 
breeding seasons. Rates of EE2 decline in the 
plasma suggested a contraceptive life of 16, 26, and 
48-60 months for the 1.5-9, 3-9, and 8-9 doses, 
respectively (Plotka and Vevea 1990, Eagle et al. 
1992). 
Results achieved with estradiol, progesterone, 
and ethinylestradiol in mares brought to focus advan- 
tages and disadvantages of natural versus synthetic 
steroids for contraception in equids. Steroids native to 
the mare, such as estradiol and progesterone, are 
recognized by the mare's metabolic enzymes and 
degraded so rapidly that contraceptive doses must be 
so large that they are difficult or impossible to adminis- 
ter. The use of some synthetic steroids, such as 
ethinylestradiol, may delay metabolic degradation and 
permit sustained contraceptive effects and provide 
useful fertility inhibition in certain instances. Any risk, 
however small, of the passage of these synthetic 
steroids to humans or other wildlife may make regis- 
tration by regulatory agencies such as the Food and 
Drug Administration (FDA), the U.S. Department of 
Agriculture (USDA), or the Environmental Protection 
Agency (EPA) unlikely or difficult. 
lmmunocontraception 
Attention has turned to immunocontraception because 
of (1) the difficulties associated with the delivery of 
large doses of microencapsulated steroids, (2) dangers 
associated with capture and restraint of horses, 
(3) surgical procedures associated with intraperitoneal 
implants, (4) concern over long-term effects of steroi- 
dal contraception, and (5) passage of synthetic 
steroids through the food chain. One immunologically 
based contraceptive strategy involves blocking the 
release of gonadotropin-releasing hormone (GnRH) 
from the hypothalamus, thereby preventing pituitary 
secretion of follicle-stimulating hormone (FSH) and 
luteinizing hormone (LH) and their subsequent tropic 
actions on the ovary or testes (Schanbacher 1984). 
Immunization of domestic mares against GnRH 
blocked ovulation in three of five mares for 4 months 
(Safir et al. 1987). Each mare was inoculated with 
2 mg of GnRH conjugated to human serum albumin 
emulsified in Freund's Complete Adjuvant (FCA). 
Analysis of plasma LH revealed a lack of pulsatile 
secretion that was correlated with antibody titers. The 
high variability in the mares' response to the antigen 
and the subsequent variabilities in antibody titers 
suggested that this approach was unreliable. 
In a study to immunize captive wild mares with 
GnRH conjugated to ketolymphohemocyanin (KLH), 
either aluminum hydroxide (alum) or monophosphoryl 
lipid Ntrehalose 6,6-dimycolatelBCG cell wall skeleton 
(triple adjuvant, TA) was used as the adjuvant 
(Goodloe et al. 1988). Mares immunized with GnRH 
plus TA had higher antibody titers and significantly 
less ovarian follicular activity. The vaccine was field- 
tested in 29 wild mares on Cumberland Island 
National Seashore, in Georgia. The vaccine was 
freeze dried and administered as a solid biodegrad- 
able 0.25-caliber bullet by means of an air-powered 
gun. After imbedding in the tissue of the target mare, 
the compressed compound forming the biobullet 
degrades over 24 hours, releasing the antigen. A total 
of 25 treated mares survived (four died from natural 
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causes) and 17 (68 percent) produced foals, which 
was not significantly different from foaling rates of 
control mares. 
Immunization against GnRH has also been 
attempted in the stallion (Dowsett et al. 1991). Four 
weanling colts were passively immunized, either 
intramuscularly or subcutaneously, with an anti-GnRH 
antibody (Peptide Technology, Ltd., Sydney, Australia) 
and given booster inoculations approximately 75 days 
later. Colts immunized intramuscularly maintained 
plasma testosterone concentrations of < 0.1 5 ng/mL 
(equivalent to concentrations in geldings) for 5 months 
following the booster inoculations. Thereafter, testos- 
terone concentrations rose to control levels for year- 
lings. Colts immunized subcutaneously had slightly 
increased plasma testosterone concentrations (up to 
0.37 nglmL) between the two immunizations but 
decreased concentrations similar to those seen in the 
intramuscularly injected group after the second 
inoculation. Antibody titers were generally higher in 
the colts immunized intramuscularly, although sexual 
development was effectively delayed for 12 months in 
both groups of colts. 
A second immunocontraception strategy for 
equids was based on the identification of antibodies 
directed against the zona pellucida of the ovum in 
naturally infertile mares (Liu and Shivers 1982) and 
immunological cross-reactivity of equine zona-positive 
antisera and porcine sperm binding (Shivers and Liu 
1982). Liu et al. (1 989) immunized 10 captive wild 
mares and 4 domestic mares with the protein equiva- 
lent of 2,000 to 5,000 porcine zonae pellucidae. FCA 
was used for the first inoculation and Freund's Incom- 
plete Adjuvant (FIA) for the three monthly booster 
inoculations that followed. Of the 14 treated mares, 
13 failed to conceive during the first year. The four 
domestic mares all conceived during the second year 
after antibody titers decreased. 
A field test of the PZP vaccine was carried out on 
Assateague Island National Seashore (Kirkpatrick et 
al. 1990). For the test, 26 wild mares were remotely 
inoculated with approximately 5,000 porcine zonae 
pellucidae (65 pg protein) and FCA in March 1988 by 
means of barbless darts. The mares received a 
second inoculation with PZP + FIA 2 weeks later, and 
18 of the mares received a third inoculation with that 
combination 1 month later. No foals were produced by 
the treated mares, whereas 50 percent of the 6 sham- 
injected mares (controls) produced foals, and 45 
percent of 11 untreated mares produced foals. Post- 
treatment foaling rate for the PZP-treated mares was 
significantly different (P < 0.002) than that for the 2 
pretreatment years, for sham-treated control mares 
and for untreated mares. Of the 26 PZP-treated 
mares, 14 were pregnant at the time of inoculation, 
and all 14 produced healthy foals 2-3 months follow- 
ing PZP treatment. Thus, the PZP vaccine had no 
effect on pregnancies in progress or the health of the 
foals born. Social behaviors and organization were 
also unaffected by treatment. Once antigen recogni- 
tion had taken place, a single annual booster inocula- 
tion was sufficient to maintain contraception. 
In March 1989, 14 of the previously treated 
mares were given a single booster inoculation. A year 
later, only one foal was produced. The 12 mares 
immunized in 1988 but not given a booster in 1989 
produced 5 foals, demonstrating for a second time the 
reversibility of the vaccine's contraceptive effects 
(Kirkpatrick et al. 1991a). After 6 consecutive years of 
booster inoculations among the Assateague mares 
and 104 mare-years (the number of mares treated 
x the number of years of treatment), four foals have 
been produced, for an effectiveness of 96 percent. 
Over the 6-year period, the difference between foaling 
rates among treated and untreated mares was highly 
significant (P<  0.001). 
Field trials were initiated in 1992 with feral 
donkeys in Virgin Islands National Park. Sixteen 
adult female donkeys received an initial inoculation of 
65 yg of porcine zonae pellucidae + FCA, a second 
identical inoculation 3 weeks later, and a third 10-12 
months later. Eleven untreated adult females were 
used as controls. Results were not calculated until 
12 months after the initial inoculation in order to allow 
for any pregnancies already in progress at the time of 
inoculations. Based on observed foals and on fecal 
steroid analysis (Kirkpatrick et al. 1991 b and c), of the 
treated females, only 1 of 16 (6.2 percent) produced a 
foal or was pregnant, while among the controls, 6 of 
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11 (54.5 percent) produced foals or were pregnant. 
The difference between foaling and pregnancy rates 
between the two groups was highly significant (P< 0.01). 
Large-scale field trials with wild horses were 
initiated in December 1992 in Nevada. Slightly more 
than 500 wild horses were captured by driving them by 
helicopter into a trap and portable corrals. Adult 
mares (n = 131 ) between the ages of 4 and 12 were 
included in the study. All mares were freeze-branded 
with numbers for later identification. One group 
received two inoculations of PZP about 3 weeks apart 
with FCA used for the first inoculation and FIA for the 
second. A second group received only a single 
inoculation + FCA. A third group received a single 
inoculation of porcine zonae pellucidae + FCA that 
contained another 65 pg of pellucidae in lactide- 
glycolide microspheres. These microspheres were 
designed to release the antigen over a 4- to 6-week 
period. 
During September 1993, fecal samples were 
collected from 78 treated or control animals and 
analyzed for steroid hormones and steroid hormone 
metabolites, which signal pregnancy (Kirkpatrick et al. 
1991 b and c). Of 27 untreated mares, 14 (52 percent) 
were pregnant. Of 17 sham-injected controls, 9 of 17 
(53 percent) were pregnant. None of 14 mares 
receiving 2 inoculations of porcine zonae pellucidae 
were pregnant. Of 20 mares receiving only a single 
inoculation of raw pellucidae, 6 (30 percent) were 
pregnant. No samples were recovered from mares 
receiving the porcine zonae pellucidae in 
microspheres. 
During June 1994, after aerial foal counts, a total 
of 65 experimental mares were observed, and foaling 
results were in general agreement with pregnancy 
data. From 32 mares that received 2 inoculations, 
only a single foal was observed. Of 16 sham-treated 
mares, 10 had foals (63 percent), and of 7 mares 
receiving only a single inoculation, 3 had foals (43 
percent). Of 10 mares receiving a single inoculation 
of the microencapsulated porcine zonae pellucidae, 
none had foals. These data suggested a contracep- 
tive effect of a single inoculation with microencapsu- 
lated porcine zonae pellucidae that lasted 8-9 months 
following treatment. 
The PZP vaccine has also been tested in captive 
exotic equids, including 23 Przewalski's horse (Equus 
przewalskii), 1 onager (E. hemionus), and 26 zebra 
(E. zebra grevyi) (Kirkpatrick et al. 1992b, 1993). 
Thus far, results are available only for the Przewalski's 
horses and the onager, and the vaccine has been 
100-percent effective in preventing pregnancies in 
these species (Kirkpatrick et al. 1993). It is better than 
80-percent effective in zebras. 
Two important issues are raised with regard to 
PZP immunocontraception of equids. The first is the 
possibility of long-term effects of the vaccine on 
ovarian function. PZP-induced contraception is 
thought to be due to a block to fertilization (Liu et al. 
1989). At least two of the major glycopreoteins of the 
noncellular zona pellucida, ZP3 (Florman and 
Wassarman 1985) and ZP4 (Hasagawa et al. 1992), 
are necessary components of the receptor molecule 
for sperm surface molecules. The role of the ZP3 
receptor in the horse has been confirmed in vitro as a 
zona pellucida-induced acrosome reaction with horse 
sperm (Arns et al. 1991). The initial study of PZP 
immunization of horses (Liu et al. 1989) and field tests 
with the Assateague wild horses (Kirkpatrick et al. 
1990, 1991 a) demonstrated that the contraceptive 
effects of PZP immunization were reversible after 
1 year of treatment. Plasma progesterone concentra- 
tions during the year of treatment indicated a luteal 
phase and therefore evidence of ovulation. However, 
the long-term effects of continuous PZP immunization 
have not been described in either the horse or other 
species. Reversibility of the contraceptive effect has 
been demonstrated in several species but only after 
short-term application of the vaccine (Gulyas et al. 
1983, Sacco et al. 1987, Liu et al. 1989). 
In the dog and the rabbit, PZP immunization 
appeared to be very damaging to ovarian follicles and 
often led to cessation of ovarian function, with accom- 
panying anovulation and depression of estrogen 
concentrations (Wood et al. 1981, Mahi-Brown et al. 
1985). Unusually large doses (5,000 pg) caused 
anovulation in the baboon (Dunbar et al. 1989). 
These data suggested that the antibody response of 
the treated animal attacks not only the zona pellucida 
of the mature ovum but oocytes and possibly other 
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Table 1. Antibody titers in response to porcine zonae pellucidae in domestic mares after one inoculation using 
porcine zonae pellucidae plus PZP-containing microspheres or two inoculations of porcine zonae pellucidae given 
3 weeks aDart 
Dates of inoculation 
Treatment Horse 311 3 412 4116 517 6118 10114 
Antibody titers (% of positive reference serum) 
FCA-PZP bolus Aldo 5 99 114 131 106 79 
& PZP microspheres Mia 4 70 107 123 82 28 
Imo 6 33 70 95 98 131 
Lab 5 38 76 120 114 
Dee 5 56 108 106 
-- 
99 
FCA-PZP bolus + Ant 4 90 130 131 152 115 
FIA-PZP bolus Con 6 66 145 135 144 58 
3 weeks later Len 8 58 118 123 91 35 
Rou 3 73 116 133 123 79 
Sou 4 67 147 126 136 94 
FCA = Freund's Complete adjuvant. FIA = Freund's Incomplete 
adjuvant. 
ovarian tissue with resulting changes in estradiol and 
progesterone secretion. These effects have not been 
demonstrated in the horse after short-term use, but 
there is evidence that these same effects may appear 
after long-term use. 
After 3 consecutive years of PZP treatment, 
three of seven Assateague mares showed decreased 
urinary estrogen concentrations and no evidence of 
ovulation (Kirkpatrick et al. 1992a), and after 6 con- 
secutive years of ovulation, five mares showed no 
evidence of ovulation. However, three of these five 
mares showed recurring rhythmic estrogen peaks, 
suggestive of developing follicular waves, and two of 
these five mares demonstrated classical estrous 
behavioral concurrent with an estrogen peak and 
permitted breeding (Kirkpatrick, unpubl. data). Another 
mare demonstrated a luteal-phase urinary progester- 
one metabolite pattern after 5 consecutive years of 
treatment and 1 year off, suggesting that normal 
ovarian function returned. The next 3-5 years will 
provide critical data regarding the effects of the PZP 
vaccine on ovarian function and reversibility after long- 
term vaccination with porcine zonae pellucidae. 
The second critical issue is related to the number 
of initial inoculations necessary for contraception. 
While it has been clearly established that two inocuia- 
tions, given 3-6 weeks apart, will provide contracep- 
tion for about a year, the need to give two inoculations 
decreases the usefulness of the vaccine for wild and 
feral equids. Thus, the single most important direction 
for future research is the development of a one- 
inoculation form of the vaccine which provides at least 
a full year, and ideally 2-3 years, of contraception 
protection. 
In an initial attempt to develop a one-inoculation 
PZP vaccine, the PZP antigen was incorporated into 
nontoxic, biodegradable, 50-p, homogenous lactide- 
glycolide microspheres. Upon i.m. injection, the 
iactide-glycolide material erodes, releasing the 
anitgen over predetermined periods of time (Eldridge 
et al. 1989). The carrier itself is metabolized to lactic 
acid and carbon dioxide. 
Five domestic mares were inoculated with an 
initial bolus of 65 pg of porcine zonae pellucidae + 
FCA plus another 65 yg of pellucidae contained in 
microspheres. Antibody titers were compared to titers 
in mares inoculated with two doses of pellucidae 
(65 pg PZPIFCA + 65 pg PZPIFIA) given 3 weeks 
apart. Contraceptive antibody titers lasted for approxi- 
mately 200 days with the one-inoculation preparation 
(table 1). 
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This same preparation was administered to 
14 wild mares on Assateague Island. One dart failed 
to inject. That mare, plus only one other mare, 
produced foals following treatment. The differences 
were significant (P<  0.05) comparing either 2 foals114 
mares or 1 foal113 mares (to account for the failed 
dart) with untreated control mares. Similar research is 
currently under way to produce a one-inoculation 
vaccine using microcapsules. The microcapsules are 
made from the same lactide-glycolide material, but 
after injection they release the PZP antigen in pulses 
rather than continuously. 
Conclusions 
PZP-induced contraception of the mare may be useful 
to prevent unwanted pregnancies among wild and 
feral equids. In the case of captive exotic equids, 
such as the Przewalski's horse and the zebra, contra- 
ception may be useful to prevent the expression of 
undesirable genetic traits ("floppy mane" or the fox 
allele, for example) or merely to prevent the produc- 
tion of unwanted surplus animals without the need to 
remove animals and disrupt well-defined social 
groups. Anti-GnRH vaccines may be useful for the 
same purpose in the stallion, or simply to reduce 
aggression among stallion groups. Finally, contracep- 
tion may represent a publicly acceptable approach to 
the management of wild and feral horses inhabiting 
public lands. 
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